로딩 중…
지수 로딩 중…
Perspective Therapeutics, Inc.
CATX· NYSE· Health Care· Health Care Equipment & Services
$3.00+3.26%
2026-08-03
Financials
Valuation Metrics
Perspective Therapeutics, Inc.'s Market Cap is $343M. At end of 2025 it was $203M. Ranked #2930 of 3,112 in US market (top 94%), #1623 of 1,667 on NYSE (top 97%), #183 of 206 in Health Care Equipment & Services (top 89%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $343M | US#2,930/3,112 Sec#183/206 |
| Revenue | $618000.00 | US#2,966/3,112 Sec#207/206 |
| Net Income | $-111M | US—/3,112 Sec—/206 |
| Total Assets | $411M | US#2,813/3,112 Sec#168/206 |
| Net Assets | $347M | US#2,476/3,112 Sec#139/206 |
| Value | ||
| P/B | 0.99x | US#339/3,112 Sec#24/206 |
| P/S | 554.54x | US#2,940/3,112 Sec#206/206 |
| FCF Yield | -31.32% | US—/3,112 Sec—/206 |
| Profitability | ||
| ROE | -31.99% | US#2,632/3,112 Sec#164/206 |
| ROA | -27.05% | US#2,844/3,112 Sec#187/206 |
| Op. Margin | -19419.58% | US#2,966/3,112 Sec#207/206 |
| Revenue Growth | -77.78% | US#2,915/3,112 Sec#206/206 |
| Financial Health | ||
| Debt Ratio | 18.23% | US#198/3,112 Sec#20/206 |
| Total Debt | $4M | US#2,862/3,112 Sec#196/206 |
| FCF | $-107M | US#2,601/3,112 Sec#192/206 |
| Cash | $54M | US#2,546/3,112 Sec#169/206 |
| Current Ratio | 8.75x | US#286/3,112 Sec#19/206 |
| Performance | ||
| 1Y Return | -18.34% | US#2,629/3,112 Sec#173/206 |
| 1M Return | -17.22% | US#2,888/3,112 Sec#192/206 |
| From 52W High | -51.22% | US#2,805/3,112 Sec#182/206 |
| 1Y MDD | -58.84% | US#2,691/3,112 Sec#171/206 |
| Trading | ||
| Volume | 795,502 shares | US#1,693/3,112 Sec#125/206 |
| Trading Value | $2M | US#2,883/3,112 Sec#187/206 |
| Per Share | ||
| EPS | $-1.40 | US—/3,112 Sec—/206 |
| BPS | $2.80 | US#2,439/3,112 Sec#163/206 |